Lee, Danner & Bass’s Allergan plc AGN Stock Holding History

Lee, Danner & Bass’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,716	Closed	-$444K	–	177
2017 Q4	$444K	Buy	+2,716	New	+$487K	0.05%	137

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Lee, Danner & Bass's AGN Position: Q1 2018 in Review

Lee, Danner & Bass sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,716 shares — an estimated $444K sold.

Lee, Danner & Bass first reported a position in AGN in Q4 2017 and held it in 1 quarter. The position peaked at $444K in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Lee, Danner & Bass reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Lee, Danner & Bass sold 2,716 Allergan plc shares in Q1 2018, an estimated $444K.
Lee, Danner & Bass first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Lee, Danner & Bass's Allergan plc position peaked at $444K in Q4 2017.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Lee, Danner & Bass's 13F filing for Q1 2018, filed 2 May 2018.